Literature DB >> 7644715

A review of perineal talc exposure and risk of ovarian cancer.

B L Harlow1, P A Hartge.   

Abstract

The authors provide a detailed review of the events that led to the interest in talc as a possible ovarian carcinogen, the epidemiological studies published to date, and their perspective on the interpretation of the findings including potential limitations, biases, and issues surrounding the plausibility of a causal association. The authors conclude that the range of relative risk estimates from epidemiology, 1.0 to 1.8, is plausible, but that additional epidemiologic studies, especially prospective investigations are needed. In addition, clinicopathological studies are needed to confirm or deny the reports of talc embedded in human ovarian tissue and reports of talc migration through the human female reproductive tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644715     DOI: 10.1006/rtph.1995.1039

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

1.  Genital powder exposure and the risk of epithelial ovarian cancer.

Authors:  Karin A Rosenblatt; Noel S Weiss; Kara L Cushing-Haugen; Kristine G Wicklund; Mary Anne Rossing
Journal:  Cancer Causes Control       Date:  2011-03-10       Impact factor: 2.506

2.  Perineal use of talcum powder and endometrial cancer risk.

Authors:  Stalo Karageorgi; Margaret A Gates; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

3.  Migration of Talc From the Perineum to Multiple Pelvic Organ Sites.

Authors:  Sandra A McDonald; Yuwei Fan; William R Welch; Daniel W Cramer; John J Godleski
Journal:  Am J Clin Pathol       Date:  2019-10-07       Impact factor: 2.493

Review 4.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

5.  Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.

Authors:  Margaret A Gates; Shelley S Tworoger; Kathryn L Terry; Linda Titus-Ernstoff; Bernard Rosner; Immaculata De Vivo; Daniel W Cramer; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

6.  Perineal powder use and risk of ovarian cancer.

Authors:  Serena C Houghton; Katherine W Reeves; Susan E Hankinson; Lori Crawford; Dorothy Lane; Jean Wactawski-Wende; Cynthia A Thomson; Judith K Ockene; Susan R Sturgeon
Journal:  J Natl Cancer Inst       Date:  2014-09-10       Impact factor: 13.506

7.  C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).

Authors:  Eva Lundin; Laure Dossus; Tess Clendenen; Vittorio Krogh; Kjell Grankvist; Marianne Wulff; Sabina Sieri; Alan A Arslan; Per Lenner; Franco Berrino; Goran Hallmans; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Annekatrin Lukanova
Journal:  Cancer Causes Control       Date:  2009-03-20       Impact factor: 2.506

8.  Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.

Authors:  Katie M O'Brien; Shelley S Tworoger; Holly R Harris; Britton Trabert; Clarice R Weinberg; Renee T Fortner; Aimee A D'Aloisio; Andrew M Kaunitz; Nicolas Wentzensen; Dale P Sandler
Journal:  Int J Cancer       Date:  2021-02-01       Impact factor: 7.316

9.  Analysis of particles from hamster lungs following pulmonary talc exposures: implications for pathogenicity.

Authors:  Erika Sato; Sandra A McDonald; Yuwei Fan; Shaina Peterson; Joseph D Brain; John J Godleski
Journal:  Part Fibre Toxicol       Date:  2020-06-04       Impact factor: 9.400

10.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.